Total Valuation
Beyond Medical Technologies Inc has a market cap or net worth of €3.06M. The enterprise value is €12.73.
Market Cap€3.06M
Enterprise Value€12.73
Share Statistics
Beyond Medical Technologies Inc has 32,793,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,793,960
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Beyond Medical Technologies Inc’s return on equity (ROE) is -20.09 and return on invested capital (ROIC) is -16.58%.
Return on Equity (ROE)-20.09
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-16.58%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee3.83K
Profits Per Employee-819.70K
Employee Count3
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Beyond Medical Technologies Inc is ―. Beyond Medical Technologies Inc’s PEG ratio is -0.01.
PE Ratio―
PS Ratio534.40
PB Ratio45.96
Price to Fair Value45.96
Price to FCF-3.60
Price to Operating Cash Flow-1.59
PEG Ratio-0.01
Income Statement
In the last 12 months, Beyond Medical Technologies Inc had revenue of 11.48K and earned -2.68M in profits. Earnings per share was -0.10.
Revenue11.48K
Gross Profit11.48K
Operating Income-1.99M
Pretax Income-2.68M
Net Income-2.68M
EBITDA-2.09M
Earnings Per Share (EPS)-0.10
Cash Flow
In the last 12 months, operating cash flow was -3.10M and capital expenditures -1.00, giving a free cash flow of -3.10M billion.
Operating Cash Flow-3.10M
Free Cash Flow-3.10M
Free Cash Flow per Share-0.09
Dividends & Yields
Beyond Medical Technologies Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta21.63
52-Week Price Change-77.26%
50-Day Moving Average0.06
200-Day Moving Average0.11
Relative Strength Index (RSI)51.07
Average Volume (3m)1.54K
Important Dates
Beyond Medical Technologies Inc upcoming earnings date is Aug 31, 2026, TBA (Confirmed).
Last Earnings DateJun 1, 2026
Next Earnings DateAug 31, 2026
Ex-Dividend Date―
Financial Position
Beyond Medical Technologies Inc as a current ratio of 0.77, with Debt / Equity ratio of -608.74%
Current Ratio0.77
Quick Ratio0.77
Debt to Market Cap1.93
Net Debt to EBITDA-4.35
Interest Coverage Ratio-3.36
Taxes
In the past 12 months, Beyond Medical Technologies Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Beyond Medical Technologies Inc EV to EBITDA ratio is -7.29, with an EV/FCF ratio of -8.95.
EV to Sales1.33K
EV to EBITDA-7.29
EV to Free Cash Flow-8.95
EV to Operating Cash Flow-8.95
Balance Sheet
Beyond Medical Technologies Inc has €1.05M in cash and marketable securities with €12.93M in debt, giving a net cash position of -€11.88M billion.
Cash & Marketable Securities€1.05M
Total Debt€12.93M
Net Cash-€11.88M
Net Cash Per Share-€0.36
Tangible Book Value Per Share-€0.36
Margins
Gross margin is -225.07%, with operating margin of -17314.34%, and net profit margin of -23355.03%.
Gross Margin-225.07%
Operating Margin-17314.34%
Pretax Margin-23355.03%
Net Profit Margin-23355.03%
EBITDA Margin-18202.16%
EBIT Margin-18202.16%
Analyst Forecast
The average price target for Beyond Medical Technologies Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-807.24%